Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel plus S-1 for metastatic or recurrent breast cancer (KBCOG 07)
jRCT1091220030Completed
- Sponsor
- Kobe Breast cancer Oncology Group
- Start
- Aug 2009
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of docetaxel and tegafur in breast cancer, sponsored by Kobe Breast cancer Oncology Group. Primary endpoint: Response rate. Started Aug 2009; status: completed.
02
Drugs
docetaxeltegafur
03
Conditions
breast cancer
Beyond the preview
Go deeper on jRCT1091220030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220030.